Abstract
Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have